Cargando…
A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222942/ https://www.ncbi.nlm.nih.gov/pubmed/34175125 http://dx.doi.org/10.1016/j.vaccine.2021.05.102 |
| _version_ | 1783711589634932736 |
|---|---|
| author | Kristensen, Debra Giersing, Birgitte Hickling, Julian Kazi, Fatima Scarna, Tiziana Kahn, Anna-Lea Hsu, Vivian Gandrup-Marino, Kristoffer Menozzi-Arnaud, Marion |
| author_facet | Kristensen, Debra Giersing, Birgitte Hickling, Julian Kazi, Fatima Scarna, Tiziana Kahn, Anna-Lea Hsu, Vivian Gandrup-Marino, Kristoffer Menozzi-Arnaud, Marion |
| author_sort | Kristensen, Debra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8222942 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82229422021-06-25 A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy Kristensen, Debra Giersing, Birgitte Hickling, Julian Kazi, Fatima Scarna, Tiziana Kahn, Anna-Lea Hsu, Vivian Gandrup-Marino, Kristoffer Menozzi-Arnaud, Marion Vaccine Commentary Elsevier Ltd. 2021-12-03 2021-06-24 /pmc/articles/PMC8222942/ /pubmed/34175125 http://dx.doi.org/10.1016/j.vaccine.2021.05.102 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Kristensen, Debra Giersing, Birgitte Hickling, Julian Kazi, Fatima Scarna, Tiziana Kahn, Anna-Lea Hsu, Vivian Gandrup-Marino, Kristoffer Menozzi-Arnaud, Marion A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy |
| title | A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy |
| title_full | A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy |
| title_fullStr | A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy |
| title_full_unstemmed | A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy |
| title_short | A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy |
| title_sort | global collaboration to advance vaccine product innovations – the vaccine innovation prioritisation strategy |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222942/ https://www.ncbi.nlm.nih.gov/pubmed/34175125 http://dx.doi.org/10.1016/j.vaccine.2021.05.102 |
| work_keys_str_mv | AT kristensendebra aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT giersingbirgitte aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT hicklingjulian aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT kazifatima aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT scarnatiziana aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT kahnannalea aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT hsuvivian aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT gandrupmarinokristoffer aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT menozziarnaudmarion aglobalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT kristensendebra globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT giersingbirgitte globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT hicklingjulian globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT kazifatima globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT scarnatiziana globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT kahnannalea globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT hsuvivian globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT gandrupmarinokristoffer globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy AT menozziarnaudmarion globalcollaborationtoadvancevaccineproductinnovationsthevaccineinnovationprioritisationstrategy |